Please note that a publication can be assigned to several endpoints, i.e. the sum of publications from the individual thematic points and subpoints can be greater than the total sum of actual publications.
Authors | Year | Exposed system | Parameters | Magnetic flux density/field strength |
---|---|---|---|---|
Medeiros HR et al. | 2023 | intact cell/cell culture, SH-SY5Y (human neuroblastoma cell line) | static magnetic field | - |
Fan Y et al. | 2023 | intact cell/cell culture, PC12 (rat pheochromocytoma cells), C57BL/6 mouse | static magnetic field | - |
Yu X et al. | 2022 | intact cell/cell culture, HK-2 cells (human kidney cell line) and MDA-MB-231 cells (breast cancer cell line), animal, mouse/BALB/c (nude mice) und mouse/C57BL/6J | static magnetic field, co-exposure, also other exposures without EMF | - |
Alipour M et al. | 2022 | intact cell/cell culture, rat bone marrow-derived mesenchymal cells (BMSCs) | static magnetic field, magnetic field, 50/60 Hz, co-exposure | - |
Nieminen V et al. | 2022 | intact cell/cell culture, MCF-7 (human breast cancer cell line) | static magnetic field, magnetic field, 50/60 Hz, co-exposure, also other exposures without EMF | - |
Semeano AT et al. | 2022 | intact cell/cell culture, E14TG2a cells (mouse embryonic stem cell line) und human induced pluripotent stem cells | static magnetic field, co-exposure, also other exposures without EMF | - |
Kerschbaum-Gruber S et al. | 2022 | intact cell/cell culture | static magnetic field, also other exposures without EMF, co-exposure | - |
Yang J et al. | 2021 | intact cell/cell culture | static magnetic field | - |
Song C et al. | 2021 | intact cell/cell culture, IOSE 386 (normal human ovarian cells), SKOV 3 and HO 8910 (ovarian carcinoma cells), animal, mouse/BALB/c (nude mice), whole body | static magnetic field | - |
Rekena A et al. | 2021 | intact cell/cell culture, CHO (Chinese hamster ovary) cells | static magnetic field | - |
This website uses cookies to provide you the best browsing experience. By continuing to use this website you accept our use of cookies.